Vor Biopharma's total assets for Q1 2025 were $109.31M, a decrease of -23.50% from the previous quarter. VOR total liabilities were $43.24M for the fiscal quarter, a -6.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.